Point72 Asset Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,000,000
| Closed | -$50.8M | – | 4274 |
|
|
2025
Q4 | $50.8M | Sell |
2,000,000
-1,442,078
| -42% | -$32.2M | 0.08% | 400 |
|
|
2025
Q3 | $55.5M | Buy |
3,442,078
+105,828
| +3% | +$1.71M | 0.12% | 248 |
|
|
2025
Q2 | $53.4M | Buy |
3,336,250
+2,534,323
| +316% | +$38.3M | 0.13% | 240 |
|
|
2025
Q1 | $13.7M | Buy |
+801,927
| New | +$16.8M | 0.04% | 567 |
|
|
2024
Q2 | – | Sell |
-1,383,810
| Closed | -$44.7M | – | 2192 |
|
|
2024
Q1 | $44.7M | Sell |
1,383,810
-1,283,073
| -48% | -$46.8M | 0.13% | 227 |
|
|
2023
Q4 | $112M | Buy |
+2,666,883
| New | +$98.1M | 0.34% | 76 |
|
|
2023
Q3 | – | Sell |
-457,467
| Closed | -$8.68M | – | 2705 |
|
|
2023
Q2 | $8.68M | Buy |
+457,467
| New | +$8.53M | 0.03% | 633 |
|
|
2023
Q1 | – | Sell |
-435,751
| Closed | -$7.73M | – | 2441 |
|
|
2022
Q4 | $7.73M | Sell |
435,751
-1,531,549
| -78% | -$19.3M | 0.03% | 631 |
|
|
2022
Q3 | $11M | Buy |
+1,967,300
| New | +$9.62M | 0.05% | 482 |
|
|
2022
Q2 | – | Sell |
-459,300
| Closed | -$2.53M | – | 1542 |
|
|
2022
Q1 | $2.53M | Sell |
459,300
-441,200
| -49% | -$2.75M | 0.01% | 836 |
|
|
2021
Q4 | $7.67M | Buy |
+900,500
| New | +$7.43M | 0.03% | 580 |
|
|
2021
Q2 | – | Sell |
-187,900
| Closed | -$3.01M | – | 1077 |
|
|
2021
Q1 | $3.01M | Sell |
187,900
-70,500
| -27% | -$1.86M | 0.02% | 670 |
|
|
2020
Q4 | $11.9M | Sell |
258,400
-1,254,866
| -83% | -$58M | 0.06% | 400 |
|
|
2020
Q3 | $53.3M | Buy |
1,513,266
+1,363,623
| +911% | +$41M | 0.29% | 87 |
|
|
2020
Q2 | $3.64M | Buy |
149,643
+126,251
| +540% | +$2.71M | 0.03% | 525 |
|
|
2020
Q1 | $364K | Buy |
+23,392
| New | +$352K | ﹤0.01% | 684 |
|
Other funds holding IMVT
DTC
BBA
TCM
VPM
VCM
